Navigation Links
The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
Date:1/7/2009

WHITE PLAINS, N.Y. and KANSAS CITY, Kan., Jan. 7 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and The University of Kansas Cancer Center have announced a partnership to translate discoveries by LLS-funded researchers into Phase I clinical trials.

Currently, The University of Kansas Cancer Center (KU Cancer Center) and its partner, Beckloff Associates Inc., are supporting two early stage projects of LLS-funded researchers at The University of Virginia and The University of Toronto. The number of projects is expected to expand over the year.

The University of Kansas is uniquely positioned to work with LLS to accelerate the research it funds. KU Cancer Center has a long history of developing cancer drugs and currently has the No. 1 pharmacy school, in terms of National Institutes of Health (NIH) funding. KU Cancer Center holds a development contract with the National Cancer Institute (NCI) and has helped formulate seven out of the 19 drugs developed through NCI's Developmental Therapeutics Program.

Integral to moving projects rapidly into clinical trials is KU Cancer Center's partnership with industry. Beckloff Associates Inc., based in Overland Park, KS, provides development and regulatory support on the projects. Through these collaborative efforts and the formation of multi-disciplinary, multi-organizational, high-performance project teams, drug projects are advanced rapidly.

The partnership between KU Cancer Center and LLS is part of LLS's Therapy Acceleration Program, which supports private sector and academic-based projects with the goal of moving blood cancer therapies into the development pipeline. KU Cancer Center is the first academic partner in the program.

"By leveraging the capabilities and strengths The University of Kansas has in place, this partnership brings
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Grape Seed Extract Kills Leukemia Cells in Lab
2. Stem cells and leukemia battle for marrow microenvironment
3. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
4. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
5. Dismissed leukemia drug helps cll patients, studies show
6. Novel treatments show improvements in survival and response rates for leukemia and lymphoma
7. Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma
8. 50 years of hairy-cell leukemia research to be observed
9. Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
10. Adult survivors of childhood leukemia have lower bone mineral density, study finds
11. UCSD researchers identify potential new drug target for chronic leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...g rates to bring unprecedented medical, economic b...27 (HealthDay News) -- The number of people with d... over the next 25 years, a new study predicts. ,... million people with the disease, up from 23.7 mil...eating people with diabetes will triple, the study...
(Date:11/27/2009)... Voyant Health™ announced...n) has licensed its TraumaCad Enterprise orthopedi...kflow solution. , (PRWEB)...ed today that Spectrum Health (Grand Rapids, Michi...dic templating solution and its TraumaCad Extend w...
(Date:11/27/2009)... Specialist manufacturers who u...ts are saving millions of dollars by bringing in t...ess. Increasing numbers of pro-active medical manu... at the concept stage of their projects, ensuring ...design processes or potentially outdated technolog...
(Date:11/26/2009)..., NEWYORK,Nov.27/PRNewswire/--Withcoldandfluseason...cestocontrolthespreadofinfectionsandavoidillness. ...althy,buttoavoidtransmittingillnessifwe,resick,"sa...trol),nursingdirectorforinfectioncontrolandoccupat...ttan. ,, HospitalforSpecialSurgeryhasoneofthelo...
(Date:11/26/2009)...he next 25 years, the number of Americans living w...3.7 million in 2009 to 44.1 million in 2034. Over ...triple, rising from $113 billion to $336 billion, ..., researchers based at the University of Chicago r... The number of those with diabetes covered by Med...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...ound that the deadly strain H5N1 strain of bird fl...dead chickens found in Siberia all infected with t...d that all the five dead chickens were from Omsk r...ov, the centre's general director said that the de...
...s decided to go ahead with implementing some refor... being the merger of the three ambulance services ...he idea in integrating the services is that it wil...de redundant, the frontline services are expected ...
...stroke") affects 300, 000 Americans each year. A p...have subsided by the time they reach an emergency ...from a major stroke in 90 days with 64 percent hav...rgency Medicine Annual Meeting, May 18-21, 2006 in...
...ajor Thales has signed a pact with the foreign min...highly// qualified postgraduates from India and Ch...rant of at least $12,700 per annum depending on th... will be invited to follow an advanced specialised...
...et themselves screened for HIV, city-run medical c...for HIV testing. According to the new rule, counse...neccessary for voluntary HIV/AIDS testing. All tha...unseling. Two hospitals and city clinics that test...
...blic health probelm in the U.S. A U.S. government ...s with drug addiction// problems will double to ap...early 2.5 million Americans have been said to have...an be partly blamed for the present trend, and an ...
Other Medicine News:Health News:Prompt Diagnosis Could Be Life-Saving In Mini-Strokes 2
(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/--Hologic,Inc.(Hologic...ufacturerandsupplierofpremiumdiagnostics,medicalim...hehealthcareneedsofwomen,isusingtheannualmeetingof...ickPlaceinChicago,November29throughDecember3,2009t...agnosticmammographyworkstationsoftware. ,, TheH...
(Date:11/25/2009)...J.,Nov.25/PRNewswire/--TheFDAgrantedtraditionalapp...cleosidereversetranscriptaseinhibitor(NNRTI).INTEL...atment-experiencedadultswhoareexperiencingvirologi...antiretroviral(ARV)agents.Thetraditionalapprovalis...1andDUET-2.INTELENCEiscurrentlymarketedintheU.S.by...
(Date:11/25/2009)...ov.25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Medi...q: CSKI ),a,leadingfullyintegratedpharmaceuticalco...nthePeople,sRepublicofChina("PRC"),today,announced...itutefor,theControlofPharmaceuticalandBiologicalPr...itsDiagnosticKitforHumanProstateSpecific,Antigen(C...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Hearing Aid Advice Just A Click Away 55834 1Hearing Aid Advice Just A Click Away 55834 2Five Ways to Change Americas Healthcare System 3A 55831 1Five Ways to Change Americas Healthcare System 3A 55831 2Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 55828 1Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 55828 2Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 55828 3Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 55828 4Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 55828 5
...LINTHICUM, Md., April 27 Pomegranate juice may ...ncer recurrence, according to new long-term resear...entific Meeting of the American Urological Associa...dergone treatment for localized prostate cancer co..., The two-stage clinical trial followed a total of...
...Unique GeneXpert(R) System Capabilities Enable Pow...., April 27 Cepheid (Nasdaq: CPHD ) today annou...ark product under the European Directive on In Vi...e, European clinicians will have access to a rapid...ium tuberculosis (MTB) and resistance to rifampic...
Other Medicine Technology:Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 3Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 4Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 5Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 6
HighTide Diabetic
Cam Walker® II
AnkleWALKER™ by DJ!
...e is designed for the treatment of diaphyseal frac...n provides post operative support following intra ...nal fixation. The brace allows for movement of joi...vascularity and encouraging bone growth. For a mor...
Medicine Products: